PRODUCT DESCRIPTION:

Albendazole 400 MG + Ivermectin 6 MG Tablets combine two powerful anthelmintic agents to offer broad-spectrum protection and treatment against mixed parasitic infections.

Albendazole interferes with microtubule formation in intestinal parasites, while Ivermectin enhances inhibitory neurotransmission in nerve and muscle cells of worms, leading to paralysis and death.

This synergistic formulation is widely used in mass deworming programs, public health initiatives, and targeted therapies for intestinal and systemic helminthic infestations.

Its single-dose oral administration ensures high compliance and efficacy, particularly in community-wide distribution campaigns.

Formulation & Presentation:

• Dosage Form: Tablets
• Presentation: Available in Blister Pack or HDPE Bottle (As per market requirement)
• Available Strengths:
  • Albendazole: 400 MG + Ivermectin: 6 MG Tablets
• Route of Administration: Oral (As per physician’s discretion or therapeutic indication)

Therapeutic Indications:

• Mixed intestinal helminthic infestations
• Strongyloidiasis
• Filariasis
• Onchocerciasis
• Mass deworming programs targeting soil-transmitted helminths (STHs)
• Suitable for preventive chemotherapy in endemic regions

Side Effects:

• COMMON:
  • Dizziness
  • Abdominal discomfort
  • Nausea
  • Fatigue
  • Mild skin rash
• SERIOUS (RARE):
  • Severe allergic reactions
  • Visual disturbances
  • Hepatotoxicity (with prolonged use)
  • Neurotoxicity (in cases of overdose or misuse)
• PRECAUTIONS:
  • Not to be used during the first trimester of pregnancy
  • Avoid alcohol consumption during and after treatment
  • Monitor liver enzymes in patients with hepatic impairment
  • Use caution in individuals with neurological disorders
  • Not recommended in children under 2 years unless directed by a physician